Molecular and Cellular Biochemistry

, Volume 119, Issue 1–2, pp 179–184 | Cite as

Molecular characteristics in Japanese patients with lipidosis: Novel mutations in metachromatic leukodystrophy and Gaucher disease

  • Yoshikatsu Eto
  • Hiroshi Kawame
  • Yoriyasu Hasegawa
  • Toya Ohashi
  • Hiroyuki Ida
  • Toshiharu Tokoro
Cellular Function and Metabolism

Abstract

The characterization of mutations in Japanese patients with lipidosis, particularly in metachromatic leukodystrophy (MLD) and Gaucher disease has been studied in detail. Metachromatic leukodystrophy is characterized by an accumulation of sulfatide in nervous tissues and kidney due to a deficiency of arylsulfatase A (ASA). We analyzed the presence of three known mutant arylsulfatase A alleles in Japanese patients with MLD. Among 10 patients of Japanese patients with MLD, we found that allele 445A mutation has moderately high incidence and also homozygosity of this mutation results in the late infantile form. Allele 2381T was not found in Japanese patients. Furthermore, we found novel mutation which is G- to A mutation at the 1070 nucleotide of the ASA gene (designated 1070 A) in Japanese patients with juvenile onset. This mutation results in a amino acid substitution of Gly245 by Arg and found in heterozygote form. Our studies of molecular analysis in 10 Japanese patients with MLD indicate that Japanese MLD patients have unique characteristics of ASA mutations compared with those of Caucasian patients. On the other hand, Gaucher disease is the most prevalent sphingolipidosis, characterized by an accumulation of glucocerebroside in macrophage derived cells due to a deficiency of lysosomal hydrolase glucocerebrosidase. To study the molecular basis of Gaucher disease in Japanese patients, we analyzed the presence of the two known mutations (6433C and 3548A) in the glucocerebrosidase gene of 15 patients with Gaucher disease. We found that the 6433C and 3548A mutations occur in all subtypes of Japanese patients with Gaucher disease. Most frequent mutations among them was the 6433C mutation, 40% of 30 chromosomes, whereas the novel mutation of the 3548A found in Japanese patients with neuronopathic Gaucher disease was found in 20% (6 out of 30 chromosomes). The characteristics of these mutations in Japanese patients with Gaucher disease is different from those of Caucasian populations reported previously.

Key words

gene analysis arylsulfatase A gene metachromatic leukodystrophy glucocerebrosidase gene Gaucher disease 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mehl E, Jatzkewitz H: Evidence for the genetic block in metachromatic leukodystrophy. Biochem Biophys Res Commun 19: 407–411, 1965Google Scholar
  2. 2.
    Stein C, Gieselman V, Kreysing J, Schmidt B, Pohlmann R, Waheed A, Meyer HE, O'Brien JS, Von Figura K: Cloning and expression of human arylsulfatase A. J Biol Chem 264: 1252–1259, 1989Google Scholar
  3. 3.
    Kreysing J, Von Figura K, Gieselmann V: Structure of the arylsulfatase A gene. Europ J Biochem 191: 627–631, 1990Google Scholar
  4. 4.
    Polten A, Fluharty AL, Fluharty CB, Kappler J, Von Figura K, Gieselmann V: Molecular basis of different forms of metachromatic leukodystrophy. N Engl J Med 324: 18–22, 1991Google Scholar
  5. 5.
    Bohne W, Von Figura K, Gieselamm V: An 11 bp deletion in the arylsulfatase A gene of a patient with late infantile metachromatic leukodystrophy. Hum Genet 87: 155–158, 1991Google Scholar
  6. 6.
    Gieselmann V, Fluharty AL, Tonnesen T, Von Figura K: Mutations in the arylsulfatase A pseudodeficiency allele causing metachromatic leukodystrophy. Am J Hum Genet 49: 407–413, 1991Google Scholar
  7. 7.
    Fluharty AL, Fluharty CB, Bohne W, Von Figura K, Gieselmann V: Two new arylsulfatase A (ARSA) mutations in a juvenile metachromatic leukodystrophy (MLD) patient. Am J Hum Genet 49: 1340–1350, 1991Google Scholar
  8. 8.
    Kappler J, Von Figura K, Gieselmann V: Late onset metachromatic leukodystrophy: Molecular pathology in two siblings. Ann Neurol 31: 256–261, 1992Google Scholar
  9. 9.
    Brady RO, Kanfer JN, Shapiro D: Metabolism of glucocerebrosidase. II. Evidence of an enzymatically deficiency in Gaucher's disease. Biochem Biophys Res Commun 18: 221–225, 1965Google Scholar
  10. 10.
    Sorge J, West C, Westwood B, Beutler E: cDNA cloning of human glucocerebrosidase gene. Proc Natl Acad Sci USA 82: 7289–7293, 1985Google Scholar
  11. 11.
    Tsuji S, Choudary PV, Martin BM, Winfield S, Barranger JA, Ginns EI: Nucleotide sequence of cDNA containing the complete coding sequence for human lysosomal glucocerebrosidase. J Biol Chem 261: 50–53, 1985Google Scholar
  12. 12.
    Tsuji S, Choudary PV, Martin BM, Major JA, Barranger JA, Ginns EI: A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher disease. N Engl J Med 316: 570–575, 1987Google Scholar
  13. 13.
    Theophilus BDM, Latham T, Grabowski GA, Smith FI: Gaucher disease: Molecular heterogeneity and phenotype-genotype correlation. Am J Hum Genet 45: 212–225, 1989Google Scholar
  14. 14.
    Beutler E, Gilbart T, Kuhl W, Sorge J, West C: Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state. Proc Natl Acad Sci, USA 88: 10544–10547, 1991Google Scholar
  15. 15.
    Latham T, Grabowski GA, Theophilus BDM, Smith FI: Complex allele of the acid beta-glucosidase gene in Gaucher disease. Am J Hum Genet 47: 79–86, 1990Google Scholar
  16. 16.
    Kawame H, Eto Y: A new mutation glucocerebrosidase-gene missense mutation responsible for neuronopathic Gaucher disease in Japanese patients. Am J Hum Genet 49: 1378–1380, 1991Google Scholar
  17. 17.
    Maniatis T, Fritsch EF, Sambrook J: Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1982Google Scholar
  18. 18.
    Hasegawa Y, Kawame H, Eto Y: Mutations in arylsulfatase A (ASA) gene of Japanese patients with metachromatic leukodystrophy (MLD). DNA and Biology, in press, 1992Google Scholar
  19. 19.
    Kawame H, Maekawa K, Eto Y: Molecular screening of Japanese patients with Gaucher disease: Phenotypic variabilities in the same genotypes. Human Mutation, in press, 1992Google Scholar
  20. 20.
    Kondo R, Wakamatsu N, Yoshino H, Fukuhara N, Miyatake T, Tsuji S: Identification of a mutation in the arylsulfatase A gene of a patient with adult-type metachromatic leukodystrophy. Am J Hum Genet 48: 971–978, 1991Google Scholar
  21. 21.
    Sidransky E, Tsuji S, Martin BM, Stubblefield B, Ginns EI: DNA mutation analysis of Gaucher disease. Am J Med Genet 42: 331–336, 1992Google Scholar
  22. 22.
    Masuno M, Tomatsu S, Sukegawa K, Orii T: Non-existence of a tight association between a 444 Leucine to proline mutation and phenotypes of Gaucher disease: High frequency of a Nci I polymorphism in the non-neuronopathic form. Hum Genet 84: 203–206, 1990Google Scholar
  23. 23.
    Kawame H, Hasegawa Y, Maekawa K, Eto Y: Rapid identification of mutations in the glucocerebrosidase gene of Gaucher disease patients by analysis of single strand conformation polymorphism (SSCP) Hum Genet, in press, 1992Google Scholar

Copyright information

© Kluwer Academic Publishers 1993

Authors and Affiliations

  • Yoshikatsu Eto
    • 1
  • Hiroshi Kawame
    • 1
  • Yoriyasu Hasegawa
    • 1
  • Toya Ohashi
    • 1
  • Hiroyuki Ida
    • 1
  • Toshiharu Tokoro
    • 1
  1. 1.Division of Medical Genetics and Endocrinology, Department of PediatricsTokyo Jikei University School of medicineTokyoJapan

Personalised recommendations